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Pulm onary surfac tant protein B (SP-B) enhances phospholip id film formation in vitro and is essential for normal surfactant functio n in vivo. We examined hum an fetal lung before and during explant culture for content and cellular localization of SP-B mRNA and prote in. SP-B mRNA was low in preculture specime ns (18 -20 wk) but hybridization signal increased ove r epithelial cells dur ing culture and was enha nced by dexa methasone treatment (10 nM). SP-B immunofluorescence was very low in preculture specimens, increased duri ng culture, and was uniformly intense in epithelial cells of dexam ethasone-treated tissue. With a newly developed immunoassay, SP-B protein was undetectable in preculture lung «2% of adult), appeared during culture (26 % of adul t), and was furth er increased~3-fo ld by dexamethasone treatment (86 % of adult); lung tissu e of two newborn infants contained 7-9-fold more SP-B than is found in the adult. Using Western blot with enhanced chemiluminescence, mature SP-B was undetectable in 16-wk specimens but was Pulmonary surfactant isolated from bronchoalveolar lavage fluid contains a variety of lipids and proteins. Three SP have been identified that influence surfactant structure, function, or metabolism. SP-A is a hydrophili c protein of 28 -36-kD monomer size that has a numb er of demonstrated effects on surfactant in vitro both alone and interacting with other surfactant proteins. SP-B and SP-C are lipophilic proteins of approx imately 8 and 4 kD, respectively, that co-isolate with surfactant lipids. Both of these proteins enhance the rate of phospholipid film formation and improve the surface activity of lipid mixtures in vivo (rev iewed in Ref. 1) .
SP-B appears to be critically important for surfactant function in vivo. Antib odies to SP-B inactivate a replacement surfactant prepared from pig lungs and cause severe respiratory present in 19-24-wk preculture tissue at 0.2-2.9% of the adult level. By comparison, SP-B mRNA content is 14 and 50 % of adult leve l in 19-and 24-wk lung tissue, respec tively; levels increase 3-fold during culture and a further 3-fold with dexamethason e. Based on these observed differences between mRNA and protein content, we conclude that basal SP-B gene exp ression in epithe lial ce lls of hum an fetal lung is regulated primarily at the level of translatio n or prote in stabil ity, where as glucocorticoids act transc riptionally. We specu late that SP-B protein acc umulates only as type II cells differentiate and acquire lamellar bodies for processing and storage of SP-B. (Pediatr R es 38: 668-675, 1995) Abbreviations SP , surfactant protein TBS, Tris-buffered salin e distress when instilled into the trachea of newborn animals or inoculated intraperitoneally into adult mice (2) (3) (4) . In pulmonary function studies with preterm rabbits, Rider et al. (5) found that the activity of lipid-SP-B preparations was equivalent to that of natural surfactan t. Recently, Nogee et al. (6) described the absence of SP-B mRNA and protein in lungs of two infants with congenital alveolar proteinosis who died in infancy of respiratory failure.
There is considerable information regarding developmental and hormonal regulation of SP-B mRNA. The mRNA is detected as a single transcript in human fetal lung in as early as 12 wk of gestation, and levels increase throughout the second trimester, reaching~5 0% of the adult level at 24 wk (7). The gene is expressed in alveolar type II and bronchi olar Clara cells of adult lung but not in other tissues (7, 8) . SP-B gene expression is increased by glucocorticoids and cAMP in cultured explants of rat and human lung, and by in vivo glucocorticoid treatment in fetal rats and rabbits (1, 7, 9 -11) . The glucocorticoid responses in human lung and NeI H-441 cells, which are derived from a human lung adenocarcinoma, involve both increased rate of gene transcription and stabilization of SP-B mRNA (12, 13) .
There is less information available about levels and regulation of SP-B protein in developing lung, particularly for the hum an. Weaver et at. (14) and Stahlman et al. (15) did not detect SP-B by immunohistochemistry in preculture specimens of seco nd trimester human fetal lung, whereas immunostaining was present after 48 h of explant culture (14) . In an earlier study Whits ett et at. (16) reported that dexamethasone treatment of cultured human fetal lung increased immunoreactive product using an antibody recognizing both SP-B and SP-e. In amniotic fluid, SP-B was not detected before 30 wk, and the concentration increased thereafter (17) .
In this study we have examin ed the content and cellul ar distribution of SP-B mRNA and protein in human fetal lung before and during explant cultur e. We used confocal microscopy immunofluorescence, enhanced chemiluminescence of protein blots, and a newly developed immunodot assay to address the hypotheses that 1) SP-B protein is expressed during in vivo developm ent with a pattern similar to that observed for mRNA content, and 2) explant culture and glucocorticoid treatment result in similar increases in both SP-B mRNA and protein content. Preliminary reports of this work have been publi shed (18, 19) .
METHODS

Materials
Waymouth 's MB 752/1 medium was obtained from the Cell Culture Facility, University of Pennsylvania , and supplemented with penicillin (100 U/mL), streptomycin (100 /Lg/ mL), and Fungizone (2.5 /Lg/mL) . Dexamethasone and other biochemicals were obtained from Sigma Chemical Co. (St. Loui s, MO). Radioisotopes and reagents for enhanced chem ilumin escence were purchased from Amersham Searle (Arlin gton Heights , IL), and protein molecular weight markers were obt ained from Life Technologies, Inc. (Gaithersburg, MD). Hum an fetal lung was obtained from seco nd trimester therapeutic abortions under protocols approve d by the Committee on Hum an Research at the Children's Hospital of Philadelphi a. Adult lung tissue was obtained from patients undergoing lobectomy, and samples of newborn lung were obtained postmortem.
Explant Culture
Fetal lung parenchyma was minced into Lrnrrr' bits and cultured as explants in serum-free Waymouth 's medium with or without 10 nM dexamethasone. Th e explants were maintained at 37°C in 95% air/5% COz on a rocker platform as previously described (20) , and the medium was changed daily. Tissue explants were harvested either before culture or at variou s times during cultur e.
mRNA Content
Total RNA was isolat ed from lung tissue and specific mRN A content determined by cDNA hybridization using a dot blot apparatus as previously described (7, 13) . The cDNA probes were labeled with eZp jdCTP using a random prim er labeling technique (oligo labeling kit; Pharma cia Biotech Inc. , Piscataway, NJ). Blots were expose d to Kodak XAR film with Cronex intensifying screens (DuPont Instrum ents, Wilmington, DE) for 1-5 d at -70°C, and the autoradiograms were scanned using a densitometer (Hoeffer GS 300 , Hoeffer Scientific Instrum ents, San Francisco, CA). Relative dens ities were calcul ated from linear portions of the dose-response curve for each RNA sample.
In Situ Hybridization
Hybridization studie s were performed with three lungs of 19-22-wk gestation. Tissue was harvested before culture (preculture) and after 3 d of explant culture with and with out 10 nM dexamethason e. Tissue pieces were fixed for 1 h at 4°C in 2% paraform aldehyde, 0.2% gluteraldehyde in PBS, pH 7.2. The tissue was then incub ated ove rnight in 30% sucrose in PBS , embedded in OCT (Tiss ue Tek), quic k froz en in liqu id nitrogen, and then stored at -70°C until sectioning.
Probe preparation. Linearized plasmid DNA containing full-length human SP-B cDNA was used as templ ate for the preparati on of cRNA probe (21) . The reaction was carried out as described by Prom ega Biotec (Madison WI) and contained DN A template (100 /Lg/mL) and 25 0 /LCi of ur idine 5-[ 35 Sjthiotriphosphate (1100 Ci/rnol). Sense, for negative control, and antisense cRNA probes were generated and purified as previous ly described (8) .
Hybridization. The methods have been previously described (8, 11, 22) . Briefly, three to five randomly chosen explants were embedded togeth er in each block. Five /Lm sections were cut on a cryostat microtome and four to five sections were mount ed on ovalbumin-coated glass slides. Thus, there were sections through different parts of each of several explants on each slide. The sections were rinsed in PBS, postfixed in 4% paraformaldehyde in PBS for 10 min, then incubated in 0.3% Triton X-100 in PBS for 15 min. The slides were then incubated with 1 /Lg/mL proteinase K, rinsed in several chan ges of PBS, and then incub ated in 0.25% acetic anhydrid e in 0.1 M ethanolamine, then 50% formamide in 2 X SSe. Hybrid ization was performed overni ght at 50°C by applying 10 -15 mL hybridi zation solution (50% form amide, 10% dextran sulfate, 2 X SSC, 0.25% ficoll, 0.25% BSA, 0.25% polyvinylp yrolidine 300,50 mM Tris, 0.1% sodium pyroph osph ate, 0.1% SDS) and 4.5 X 10 5 cpm of 35S-UTP-labeled riboprobe to each section. After hybrid ization, the slides were washed with SSC (4 X , 2 X, then 0.1 X) and then treated with RNase A. After stepwise dehydration in ethanol/0 .3 M ammonium acetate, slides were dipp ed in Kodak NTB2 photographic emulsion for autoradiography. They were allowed to expose for 3-5 d at 4°C and were then developed, count er stained with hematoxylin and photographed under a light microscope with a 25x Zeiss planar lens. Tissue from the different experimental conditions in each experiment were processed togeth er and exposed for the same time.
Immunostaining
Monospecific polyclonal antisera directed against bovine SP-B was produced in rabbits by injection of an organic solvent extract of bovine surfactant (Surfactant TA, Ross Laboratories). Details of the preparation and characterization of this antiserum have been previously described (23) . The antiserum recognizes both the reduced (monomer) and nonreduced (dimeric) forms of bovine, human and rat mature SP-B as well as all forms of pro-SP-B containing the mature SP-B sequence. Anti-SP-B does not show cross reactivity to SP-A, SP-C, or serum proteins. Experiments used four lungs of 12-wk gestation, 1 lung of 15 wk, and 3 of 20 wk, and tissue was examined before (12-wk samples) or before and after 5 d of explant culture (other samples).
Lung samples were fixed with 4% paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) and then washed in the sodium cacodylate buffer for 1 h. The tissue was cryoprotected in 10% sucrose in 0.1 M sodium cacodylate for 1 h, 20% sucrose in the same buffer 1 h, and 30% sucrose in the same buffer overnight at 4°C. The tissue was frozen in Freon 22 cooled to -150°C with liquid nitrogen. The samples were mounted for cryosectioning with Polyfreeze tissue freezing medium. Cryostat sections, 8 {Lm thick, were cut at -20°C, placed on gelatin/chrom-alum coated slides and air dried.
Tissue sections were immunostained based on the method of Williams et at. (24) as modified in our laboratory (25) . This method utilizes two preincubations in 0.1% sodium borohydride in PBS for 5 min to reduce endogenous fluorescence. Staining was done by sequentially incubating sections with rabbit anti-SP-B diluted 1:500 in PBS with 0.3% Triton X-l OO, 3% BSA, 5% goat serum , and finally Texas-Red conjugated goat anti-rabbit IgG (Organon Teknika, Durham, NC) diluted 1:100 in the same buffer solution. After extensive washes in PBS with and without 0.3% Triton X-100, sections were air-dried, and coverslips were sealed with Mowiol (Calbiochern, San Diego, CA).
Control slides were prepared by replacing the primary antibody with rabbit preimmune serum (diluted 1:500). All sections were examined using confocal laser fluorescence microscopy. Texas Red fluorescence was detected at an excitation wavelength of 563 nm and an emission wavelength greater than 625 nm. Photographs were made with the same number of scans and exposure for all specimens.
Quantitative Immunoblot Assay
Tissue levels of SP-B protein were measured using a quantitative immunoblot assay developed in our laboratory. Seven lungs of 19-22 wk were studied before and after culture for 4 -6 d. Fetal tissue was sonicated (6 s with a microtip) in a solution of protease inhibitors containing 10 mM benzamidine, 50 mM N-ethylmaleimide, and 10 mM phenylmethylsulfonyl fluoride. Newborn and adult lung samples were pulverized in liquid nitrogen with a mortar and pestle before sonication. Protein concentration was determined by the assay of Bradford using bovine IgG as standard (26) . Samples of sonicated tissue (200 J.LL total volume) of known protein content were serially diluted in PBS, pH 7.5, and spotted onto a gridded nitrocellulose paper using a vacuum-assisted 96-well dot-blot apparatus (Bio-Rad, Rockville Center, NY). After drying, the nitrocellulose blot was blocked using 2% gelatin in TBS and washed using Tween (0.05%) in TBS. The blots were incubated 2 h in a primary antibody solution consisting of anti-SP-B in Tween-TBS (1:1000) followed by a 3-h incubation in secondary antibody solution containing an 1251-labeled goat anti-rabbit antisera (0.1-0.2 mCi/mL). The blot was washed extensively in Tween-TBS and dried. The 125 1 radioactivity of each spot was measured directly by f3 scanning using an Ambis 4000 radioanalytic imaging detector and quantified using Ambis image analysis software. Net counts (corrected for background counts from a sample blank) were obtained for each dot, and data were collected in a Data Information File (OIF) and plotted on a semilogarithmi c plot using Sigma Plot (Jandel Scientific, San Rafael, CA). Because of the problems associated with obtaining reliable protein content measurements for hydrophobic surfactant proteins (27) , we chose to normalize the data to SP-B in bovine surfactant. A single preparation of bovine surfactant prepared in our laboratory (23) was used as an internal standard for all assays, and data for lung samples are expressed as percent of bovine surfactant SP-B. Assays were performed in duplicate on tissue from duplicate culture dishes and SP-B content was read from the linear portion of the standard and unknown sample curves.
SDS-PAGE and Western Blot
Lung sonicates were subjected to SDS-PAGE using TrisTricine buffer according to the method of Schaegger and von Jagow (28) , and proteins were transferred electrophoretically overnight to nitrocellulose as previously described (23) . After transfer, immunoblotting was performed with anti-SP-B antiserum (1:1000), and secondary goat anti-rabbit IgG antisera was conjugated with horseradish peroxidase (1:2000) (23). Color was developed usin g 4-chloronaphthol (Bio-Rad, Melville, NY) following the manufacturer's instruction s. For analysis of preculture lung specimens, which have very low levels of SP-B, we used anti-SP-B antiserum at 1:4000 and secondary goat anti-rabbit IgG antisera at 1:10,000 and detected immunoreactive product with enhanced chemiluminesence according to the manufacturer's directions. Density of the SP-B bands was quantitated using a scanning densitometer (GS300, Hoefer Scientific Instruments, San Francisco, CA) under exposure conditions that provided a linear response to amount of loaded protein.
RESULTS
In situ hybridization. Previous studies with human lung used Northern and dot blot hybridization to determine content of SP-B mRNA during development and in explant culture. In this study we performed in situ hybridization to examine cellular distribution and relative levels of message. The overall hybridization signal with SP-B antisense probe in sections of lung before culture was similar to the background levels seen with sense probes (Fig. 1, a versus d) . However, most preculture sections had some regions of increased hybridization over epithelial cells, consistent with our previous finding that mid- trimester human fetal lung contains detectable SP-B RNA, albeit at a fraction of the levels found in adult lung. Levels of hybridiz ation over epithelial cells were clearly increased after 3 d of explant culture (Fig. Ib ) compared with preculture tissue, whereas the signal over the surrounding mesenchymal cells was not above background hybridization seen with sense probes (Fig. Id) . In sections of dexamethasone-treated tissue (Fig. 1, c, e, andf) , the hybridiz ation signal was increased in intensity over most epithelial cells compared with control tissue. The photomicrographs shown are representative of experiments with fetal lung of 19-22 wk of gestation. By bright field microscopy ( Fig. If) , lung morphology was similar to that previously described (20) .
Immunostaining. Immun oreactive SP-B was undetectable or at very low levels in all preculture fetal lungs (12-20-wk gestation). Areas of staining were only occasionally observed in the sections and were of low intensity.
Effects of culture and dexamethasone were examined in experiments with three separate lungs. In the experiment illustrated in Fig. 2 , preculture 20-wk tissue had a low level of staining of some epithelial cells (Fig. 2a) . Afte r 5 d of explant culture without serum or hormones, the intensity of immunostaining (at the same dilution of antibody) was increased, and most epithelial cells were positive (Fig. 2b) . Dexamethasone treatment of explants for 5 d resulted in very intense staining of epithelial cells and occasional intraluminal staining. Signal over the mesenchyme (Fig. 2c) was minimal and resembled the background staining seen with preimmun e serum (Fig. 2d) . Results were similar with the other two lungs.
Quantitative immunobLot assay. We developed and characterized an immunoassay for SP-B using polyclonal antiserum raised against an organic solvent extract of bovine surfactant. The intraassay and interassay coefficients of variation were 3.7% (n = 16) and 9.6% (n = 8), respectively. Serial dilutions of sonicated tissue samples consistently yielded curves parallel to a standard curve prepared with bovine surfactant (Fig . 3, a  and b) and the shape of the standard curve was not affected by addition of non-lung prot ein (rat brain homogenate, not shown). Under our usual conditio ns of tissue preparation and assay, an SP-B content equivalent to 0.02% of bovine surfactant could be reliably measured .
SP-B protein was below the level of detectability by immunoassay in all samples of preculture lung (19-22-wk gestation , n = 7). SP-B became quantifiable in control tissue after explant culture, achieving a level of 0.3% of bovine surfactant after 5 d (Table 1) . Data from one experiment in which tissue was assayed daily during culture are shown in Figure 3 . SP-B concentrat ion increased progressively (> lO-fold) between d 0 and 4 of culture.
In seven experiments tissue was cultured with and without dexamethasone for 4 d. In each experiment SP-B concentration was increased by hormone treatment and the mean value was 3-fold greater than control. The induced levels were comparable to those found in sonicate of adult human lung (Table 1) .
Western blot. We initially examined immunoreactive SP-B forms on We st ern blots using horseradish peroxidaseconjugated seconda ry antibody detected by color development (Fig. 4) 
DISCUSSION
Previous work has indicated that SP-B mRNA content in human lung is both developmentally and hormonally regulated; however, there has been little information on cellular localization of expression or content of SP-B protein in fetal lung. It has been uncertain whether the stimulatory effects of explant SP-B. Fetal samples also showed a band at~15 kD (not shown) which may represent a proteolytic cleavage product of precursor SP-B. The films from this and other blots were scanned, and data for levels of mature SP-B protein are shown in Figure 5b . Mature SP-B was undetectable in 16-wk tissue «0.1 % of adult level) but was present in all samples of 19-24 wk gestation with higher levels present at 24 wk (mean 2.9% of adult level).
To further study the relationship between content of SP-B mRNA and protein, we measured both parameters in three lungs of 21-23- present as mature monomer (~6.5 kD) with small amounts of precursor forms (~26 and 42 kD) detected in samples with increased SP-B content; this pattern was similar to that found with newborn and adult lung. The content of immunoreactive SP-B detected in fetal tissue by Western blot was qualitatively greater after dexamethasone treatment in agreement with findings by immunostaining and immunoassay.
The failure to detect SP-B protein by immunostaining in second trimester human fetal lung was surprising since as previously reported there is substantial SP-B mRNA at this stage of development (Table 1) . To further examine preculture tissue we prepared Western blots using increased amounts of protein in the gels (200 J.Lg) and enhanced chemiluminesence for detection. As shown in Figure Sa , faint bands of mature SP-B were detected in preculture lung specimens of 21-24-wk gestation. Newborn and adult samples, with lower amounts of protein loaded, showed strong bands corresponding to mature culture and glucocorticoid treatment on SP-B mRNA content involved a relatively uniform response by all epithelial cells and whether SP-B prot ein was increased proport ionally to mRNA. In this study, we addressed these issues using in situ hybridi zation and immun ocytochemical techniques.
By in situ hybridization we found low levels of SP-B mRNA in precultur e second trimester lung tissue, consistent with the previous finding by in vitro hybridiz ation (~5 to 15% of adult level for 12-20-wk tissue) (7). Hybridiz ation signal was detected in only some of the developing tubules in second trimester preculture tissue and appeared to be localized to lining cells. This pattern presumabl y reflects regional differences in expression of the SP-B gene, possibly related to buddin g of saccules. In adult human lung, SP-B mRNA is present in both type II and bronchiolar Clara cells (8) .
Two previous studies did not detect immunoreactive SP-B in preculture second trimester tissue using horseradish peroxidase immun ohistochemistry (14, 15) . Our observation of very low but detectable specific immun ofluorescence in some areas of precultur e tissue may reflect increased sensitivity of immun ofluorescence detected by laser confocal microscopy. We were unable to detect immunoreactive SP-B protein in precultur e tissue by immunoassay, but low levels were detected by Western blot after loading maximal possibl e amounts of protein and using highl y sensitive chemiluminesence for detecti on. The content of SP-B protein increased during the last part of the second trimester with a pattern comparable to that found for SP-B mRNA content (7) . The possibl e function if any of very low levels of mature SP-B in some epithelial lining cells as early as 19 wk of gestation is unknown but is probably not related to surfactant, because lamellar bodies do not normally appear until~24 wk of gestation and surfactant is not detected in amniotic fluid until -30 wk (17) . We found high levels of SP-B in term newborn infants comp ared with the adult which may reflect a relativ ely greater proportion of type II and possibl y Clara cells, increased synth etic rate, and/or decreased degrad ation.
After explant culture of fetal lung for seve ral days without serum or hormones, the percentage of positive cells and intensity of both hybridi zation and immun ostaining increased. The increased expression of SP-B and its mRNA was clearly localized to epithelial cells lining the developing saccules, confirming a previous observa tion by immunocytochemistry (14) . Some immuno reactive material was observed in the airway lumens which could represent secreted protein and/or desquamated epithelial cells. Although it is not yet determined whether SP-B in explants is incorporated into lamellar bodies, the previous finding that SP-A stimulates the rate of in vitro film formation by lamellar bodies from cultured human fetal lung supports this possibility (29) .
It is known that explant culture per se causes precocious differentiation of type II cells with appearance of lamellar bodies and increasing content of surfactant lipids and mRNAs for SP-A and SP-B. This process is mediated at least in part by endog enous prostagl andins and by cA MP which increases during culture (30, 31) . Our data indicate that the increase in immunoreactive SP-B protein during culture is -20-fold, whereas the increase in mRN A content during culture is~3 -fold. By contrast , SP-A mRNA and protein increase proportionally during culture (9) . The greater abundance of SP-B mRNA than protein in precu lture tissue and the manyfold accumulation of SP-B protein during culture indicate posttranscriptional regulati on which could reflect changes in rate of translation and/or protein degrad ation. We specul ate that processi ng of precursor SP-B to the mature form increases as epithelial cells differentiate during culture (or in vivo) and acquire multivesicular bodies and lamellar bodies (32) . The observations that monomer forms of SP-B were not detected in embryonic rat lung and glucocorticoid-treated H-441 cells, both of which contain SP-B mRNA but not lamellar bodies, support this possibility (12, 33) . Further studies using pulsechase protocols will be useful in defining SP-B synthesis, processing, and stability in the developing lung.
The distribution of riboprobe hybridization signal and immunostaining in cultur ed control tissue was nonun iform with some individual cells of a tubule or clusters of epithelial cells having higher levels of signal. By contrast, most cells in most tubul es of dexamethasone-treated tissue were uniformly positive. These patterns are similar to the morph ologic appearance of control and treated tissue with regard to type II cell differentiation (20) and are consistent with glucocorticoid causing a coordinated precocious differentiation of all epithelial cells into type II cells. It is possible that the decreased hybridization signal in some tubule s (e.g. Fig. Ib) is artifactual (e.g. nonunifo rm coating with emulsion or variation in the plane of sectioning), but it seems more likely that this variability reflects regional differences in rate of cytodifferentiation.
The response to dexamethasone is quantitatively similar for SP-B mRNA and protein. In this study we found a~3 -fo l d increase in both SP-B mRNA and protein in explants exposed to dexamethasone. Previously, Whitsett et al. (16) described a 3-fold increase by dexametha sone in surfactant proteolipid using antiserum that recognized both SP-B and SP-C. These observations indicat e that glucoc orticoids increase the content of SP-B protein primarily by increasing mRNA content, in agree ment with recent data that glucocor ticoids increase both the rate of transcription and stability of SP-B mRNA (13) .
An earlier study with cultur ed human fetal lung described e SS]methionine incorporation into immunop recipitable proteins of 42, 25, and 8 kD under reducing conditions, representing precursor and processed forms of SP-B protein (14) . We found on West ern blot that the primary immun oreactive SP-B protein in cultured tissue was the mature form (~6. 5 kD) with lower levels of 26-and 42-kD forms. This pattern resembled that of adult lung indicating that there is appropriate processing of SP-B in cultured fetal lung and that the predominant SP-B form quantitated by the immunoblot assay is the mature protein.
Cellular distribution and regulation of SP-B has been examined in rodents. In adult lung SP-B mRNA and proprotein are localized to bronchial, bronchiolar, and alveolar epithelium, with an alveolar distribution consistent with type II cells (11, 34) . In vivo dexam ethasone treatm ent increased the hybridization signal over bron chiolar and alveolar cells of both fetal and postnatal animals (11) . In a study with fetal rat lung in explant culture (10) , dexamethasone treatment increased levels of SP-B mRNA and the proportion of bronchiolar and alveolar cells expressing the gene similar to our results with human lung. To our knowledge there are no published data describing hormonal effects on SP-B protein in animal models.
The import ance of SP-B for normal lung function is becoming increasingly evident as a result of recent studies with antibodies (2) (3) (4) and the report of a congenital deficiency of SP-B (6). Many prematurely born infants are likely deficient in surfactant proteins as well as lipids and consequently experience respiratory distress and long-term lung disease . Prenatal treatment with corticosteroids reduces the incidence of respiratory distress syndrome and improves overall survival in premature infants. It is likely that induction of SP-B protein occurs with steroid therapy and is an important component of the protective response.
